RxNorm Semantic Concepts Index - 279
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "279".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 27901 | isoconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27901 | isoconazole | Designated preferred name (PT) | NO | |
| RxCUI: 27901 | isoconazole | Full form of descriptor (FN) | NO | |
| RxCUI: 27901 | isoconazole | Designated preferred name (PT) | NO | |
| RxCUI: 27901 | isoconazole | Full form of descriptor (FN) | NO | |
| RxCUI: 27902 | Isocoproporphyrin | Designated preferred name (PT) | NO | |
| RxCUI: 27902 | Isocoproporphyrin | Full form of descriptor (FN) | NO | |
| RxCUI: 279169 | Lipoprotein associated phospholipase A2 | Designated preferred name (PT) | NO | |
| RxCUI: 279169 | Lipoprotein associated phospholipase A2 | Full form of descriptor (FN) | NO | |
| RxCUI: 279169 | Lipoprotein associated phospholipase A2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27929 | Lanatoside C | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27929 | Lanatoside C | Designated preferred name (PT) | NO | |
| RxCUI: 27929 | Lanatoside C | Full form of descriptor (FN) | NO | |
| RxCUI: 27929 | Lanatoside C | Designated preferred name (PT) | NO | |
| RxCUI: 27929 | Lanatoside C | Full form of descriptor (FN) | NO | |
| RxCUI: 279327 | Oblimersen | Designated preferred name (PT) | NO | |
| RxCUI: 279327 | Oblimersen | Full form of descriptor (FN) | NO | |
| RxCUI: 279327 | Oblimersen | Designated preferred name (PT) | NO | |
| RxCUI: 279327 | Oblimersen | Full form of descriptor (FN) | NO | |
| RxCUI: 27946 | isometheptene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27946 | isometheptene | Designated preferred name (PT) | YES | |
| RxCUI: 27946 | isometheptene | Full form of descriptor (FN) | YES | |
| RxCUI: 27946 | isometheptene | Designated preferred name (PT) | YES | |
| RxCUI: 27946 | isometheptene | Full form of descriptor (FN) | YES | |
| RxCUI: 279645 | almotriptan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 279645 | almotriptan | Designated preferred name (PT) | YES | |
| RxCUI: 279645 | almotriptan | Full form of descriptor (FN) | YES | |
| RxCUI: 279645 | almotriptan | Designated preferred name (PT) | YES | |
| RxCUI: 279645 | almotriptan | Full form of descriptor (FN) | YES | |
| RxCUI: 27968 | IPD - Isophorone diamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27968 | IPD - Isophorone diamine | Designated preferred name (PT) | NO | |
| RxCUI: 27968 | IPD - Isophorone diamine | Full form of descriptor (FN) | NO | |
| RxCUI: 27968 | IPD - Isophorone diamine | Designated preferred name (PT) | NO | |
| RxCUI: 27968 | IPD - Isophorone diamine | Full form of descriptor (FN) | NO | |
| RxCUI: 279790 | Oxidized PVA hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 279790 | Oxidized PVA hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 279790 | Oxidized PVA hydrolase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 279790 | Oxidized PVA hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27985 | isopropyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27985 | isopropyl myristate | Designated preferred name (PT) | YES | |
| RxCUI: 27985 | isopropyl myristate | Full form of descriptor (FN) | YES | |
| RxCUI: 27985 | isopropyl myristate | Designated preferred name (PT) | YES | |
| RxCUI: 27985 | isopropyl myristate | Full form of descriptor (FN) | YES | |
| RxCUI: 27994 | Isopullulanase | Designated preferred name (PT) | NO | |
| RxCUI: 27994 | Isopullulanase | Full form of descriptor (FN) | NO | |
| RxCUI: 279950 | parecoxib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 279950 | parecoxib | Designated preferred name (PT) | NO | |
| RxCUI: 279950 | parecoxib | Full form of descriptor (FN) | NO | |
| RxCUI: 279950 | parecoxib | Designated preferred name (PT) | NO | |
| RxCUI: 279950 | parecoxib | Full form of descriptor (FN) | NO | |
| RxCUI: 279951 | parecoxib sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 279951 | parecoxib sodium | Designated preferred name (PT) | NO | |
| RxCUI: 279951 | parecoxib sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 279961 | Escin Ib | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |